Quick Answer
IOVANCE BIOTHERAPEUTICS, INC. reported Total Assets of $913.17 million for fiscal year 2025.
IOVANCE BIOTHERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $913.17M | +0.3% |
| 2024 | $910.43M | +16.7% |
| 2023 | $780.35M | +17.5% |
| 2022 | $663.98M | -14.6% |
| 2021 | $777.33M | +1.2% |
| 2020 | $768.46M | +123.0% |
| 2019 | $344.65M | -28.3% |
| 2018 | $480.82M | +209.5% |
| 2017 | $155.37M | -9.6% |
| 2016 | $171.89M | +62.7% |
| 2015 | $105.65M | +127.2% |
| 2014 | $46.51M | +134.0% |
| 2013 | $19.87M | +67467.6% |
| 2012 | $29.4K | -94.8% |
| 2011 | $568.4K | -61.1% |
| 2010 | $1.46M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $904.95M | -8.7% | -0.3% |
| June 30, 2025 | $907.44M | -5.9% | -6.1% |
| March 31, 2025 | $966.74M | +11.1% | +6.2% |
| December 31, 2024 | $910.43M | +16.7% | -8.1% |
| September 30, 2024 | $991.12M | +16.3% | +2.8% |
| June 30, 2024 | $964.32M | +27.3% | +10.9% |
| March 31, 2024 | $869.83M | +5.5% | +11.5% |
| December 31, 2023 | $780.35M | +17.5% | -8.4% |
- IOVANCE BIOTHERAPEUTICS, INC. showed an increase of +0.3% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, IOVANCE BIOTHERAPEUTICS, INC.’s total assets has grown by 62405.1% (from $1.46 million to $913.17 million).
- The most recent figure is from IOVANCE BIOTHERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: